Metabolic syndrome describes a group of interrelated metabolic abnormalities that commonly occur together and raise the risk of major chronic diseases. Individuals with the syndrome typically present with a mix of central (abdominal) obesity, altered lipid levels, raised blood pressure and impaired glucose regulation. Together these features increase the likelihood of developing cardiovascular disease, stroke and type 2 diabetes.

Key features and diagnostic components

Clinicians identify metabolic syndrome by detecting several coexisting risk factors rather than a single disease. Commonly used components include:

  • Central obesity (excess abdominal fat measured by waist circumference).
  • Elevated triglycerides or other abnormal blood lipids.
  • Low high‑density lipoprotein (HDL) cholesterol.
  • Raised blood pressure.
  • Elevated fasting blood glucose or insulin resistance.

Different professional groups (for example, national and international panels) have published slightly different thresholds and definitions, and criteria may be adapted for age, sex and ethnic background.

Causes and underlying mechanisms

Metabolic syndrome has no single cause. Insulin resistance—an impaired cellular response to insulin—is a central mechanism for many people and helps explain the cluster of features. Excess caloric intake, physical inactivity and excess adiposity (especially visceral fat) amplify insulin resistance. Genetics, hormonal factors and certain medications can also contribute.

Health consequences and importance

Possessing the syndrome substantially raises long‑term risk of atherosclerotic disease and progression to overt type 2 diabetes. Public health surveys suggest that around one quarter of adults in the United States meet commonly used criteria for the syndrome, making it an important target for prevention and clinical care. Management of individual components reduces risk even if the syndrome label is not removed.

Management, prevention and examples

Treatment focuses on lifestyle change and control of each risk factor. Typical measures include:

  • Weight reduction through calorie control and regular physical activity.
  • Dietary patterns that lower saturated fat and refined carbohydrates and increase whole foods.
  • Smoking cessation and limited alcohol intake.
  • Medications when needed to treat high blood pressure, dyslipidemia or hyperglycemia.

Even moderate weight loss and increased activity can improve insulin sensitivity and lipid profiles. Clinical care usually combines counseling, monitoring and targeted drug therapy.

History and distinctions

The idea that clusters of metabolic risk factors occur together has been observed for nearly a century, and the term "metabolic syndrome" entered medical use in the mid‑20th century. Contemporary use emphasizes a pragmatic grouping of modifiable risks rather than a single disease entity. For historical overviews and guideline differences see sources on diabetes mellitus and metabolic risk and on several medical conditions that contribute to cardiometabolic risk.